> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CDRH Regulatory Science Priorities
- URL: https://www.fdaweb.com/cdrh-regulatory-science-priorities/
- Published: 2019-08-22T12:00:00.000Z
- Updated: 2026-09-15T01:45:39.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5144836

CDRH is listing its 10 current regulatory science priorities that “serve as a catalyst to improve the safety, effectiveness, performance, and quality of medical devices and radiation-emitting products, and to facilitate introducing innovative medical devices into the marketplace.” An online [list](https://www.fda.gov/medical-devices/science-and-research-medical-devices/cdrh-regulatory-science-priorities?ref=fdaweb.com) gives the 10 as: 

- leverage “Big Data” for regulatory decision-making;
- modernize biocompatibility and biological risk evaluation of device materials;
- leverage real-world evidence and employ evidence synthesis across multiple domains in regulatory decision-making;
- advance tests and methods for predicting and monitoring medical device clinical performance;
- develop methods and tools to improve and streamline clinical trial design;
- develop computational modeling technologies to support regulatory decision-making;
- enhance the performance of Digital Health and medical device cybersecurity;
- reduce healthcare-associated infections by better understanding the effectiveness of antimicrobials, sterilization, and reprocessing of medical devices;
- collect and use patient input in regulatory decision-making; and
- leverage precision medicine and biomarkers for predicting medical device performance, disease diagnosis, and progression.